US Stock MarketDetailed Quotes

CLYM Climb Bio

Watchlist
  • 1.785
  • -0.035-1.92%
Trading Jan 24 12:56 ET
120.13MMarket Cap-1.05P/E (TTM)

About Climb Bio Company

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 antibody designed for a broad range of B-cell mediated diseases. The company was founded by Andrew D. Levin and Valerie Morisset on October 18, 2018 and is headquartered in Wellesley Hills, MA.

Company Profile

SymbolCLYM
Company NameClimb Bio
Listing DateAug 10, 2021
Issue Price12.50
Founded2018
CEODr. Aoife M. Brennan, M.B.
MarketNASDAQ
Employees11
Fiscal Year Ends12-31
Address20 William Street,Suite 145
CityWellesley Hills
ProvinceMassachusetts
CountryUnited States of America
Zip Code02481-4103
Phone1-866-857-2596
Websitehttp://www.climbbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Aoife M. Brennan, M.B.
  • President, Chief Executive Officer and Director
  • --
  • Dr. Stephen Thomas, PhD
  • Interim Chief Executive Officer and Director
  • --
  • Dr. Brett Kaplan, M.D.
  • Chief Operating Officer and Principal Financial Officer
  • --
  • Emily Pimblett
  • Chief Accounting Officer
  • --
  • Dr. Andrew Levin, M.D.,PhD
  • Chairman of the Board
  • 87.91K
  • Stephen Thomas
  • Director
  • --
  • Adam Rosenberg
  • Independent Director
  • 77.16K
  • Dr. Liam Ratcliffe, M.D.,PhD
  • Lead Independent Director
  • 71.33K
  • Dr. Judith A. Dunn, PhD
  • Independent Director
  • 69.66K
  • Simon Tate
  • Independent Director
  • 22.52K
  • Dr. Jan L. Hillson, M.D.
  • Senior Clinical Advisor
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
January rate meeting coming! Fed's pause in rate cuts a foregone conclusion?
🎙️Discussion 1. Will the Fed press the "pause button" on rate cuts as expected? 2. Do you think President Trump's political actions will ch Show More
Here's the Breakdown for December CPI, in One Chart
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.